Our previous studies confirmed the disordered GM and decreased SCFAs in the gut of AF patients, as well as dysregulation of the cardiac SCFA–GPR43–NLRP3 interactions during AF development and atrial remodeling [18–20]. This evidence concerns the gene NLRP3 and atrial fibrillation.